AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AROA BIOSURGERY LTD

0.525

+0.0357.14%

Volume:590.47K

Turnover:294.24K

Market Cap:181.14M

PE:48.89

High:0.525

Open:0.500

Low:0.480

Close:0.490

52wk High:0.800

52wk Low:0.480

Shares:345.03M

Float Shares:258.64M

Volume Ratio:4.56

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.011

EPS(LYR):0.013

ROE:4.86%

ROA:3.09%

PB:2.25

PE(LYR):40.70

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Aroa Biosurgery Reports Low Infection Rates in 411-Patient Myriad Soft Tissue Reconstruction Study

Aroa Biosurgery Says Study Interim Results Show Low Infection Rates, No Adverse Events Related to Myriad Products

MT Newswires Live

ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.

ASX Value Picks ALS And Two More Stocks Estimated Below Intrinsic Value

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ARX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ARX.AU\",,,,,undefined,":{"symbol":"ARX.AU","market":"AU","secType":"STK","nameCN":"AROA BIOSURGERY LTD","latestPrice":0.525,"timestamp":1790748720000,"preClose":0.49,"halted":0,"volume":590468,"delay":0,"changeRate":0.0714285714285715,"nameEN":"AROA BIOSURGERY LTD","floatShares":258636705,"shares":345033235,"eps":0.010739,"marketStatus":"Not Yet Opened","change":0.035,"latestTime":"09-30 16:12:00 AEST","open":0.5,"high":0.525,"low":0.48,"amount":294239,"amplitude":0.091837,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.010739,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.49,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":4.5615005513103535,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ARX.AU","preClose":0.49,"auctionPrice":0.525,"auctionVolume":8899,"auction":3,"marketStatus":"盘后竞价","timestamp":1790748603134}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ARX.AU\",,,,,undefined,":{"symbol":"ARX.AU","floatShares":258636705,"roa":"3.09%","roe":"4.86%","lyrEps":0.0129,"volumeRatio":4.5615005513103535,"shares":345033235,"dividePrice":0,"high":0.525,"amplitude":0.091837,"preClose":0.49,"low":0.48,"week52Low":0.48,"pbRate":"2.25","psRate":"2.15","week52High":0.8,"institutionHeld":0,"latestPrice":0.525,"eps":0.010739,"divideRate":0,"volume":590468,"delay":0,"ttmEps":0.010739,"open":0.5,"prevYearClose":0.74,"prevWeekClose":0.51,"prevMonthClose":0.525,"prevQuarterClose":0.525,"fiveDayClose":0.53,"twentyDayClose":0.54,"sixtyDayClose":0.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-05-26","symbol":"ARX.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1779753600000,"name":null,"time":"Pre-MKt","dateTimestamp":1779717600000,"actualEps":null},{"date":"2025-11-24","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763938800000,"name":null,"time":"","dateTimestamp":1763902800000,"actualEps":null},{"date":"2025-10-30","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761778800000,"name":null,"time":"","dateTimestamp":1761742800000,"actualEps":null},{"date":"2025-10-15","symbol":"ARX.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1760482800000,"name":null,"time":"Pre-MKt","dateTimestamp":1760446800000,"actualEps":null},{"date":"2025-07-28","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753660800000,"name":null,"time":"","dateTimestamp":1753624800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665398527","title":"Aroa Biosurgery Reports Low Infection Rates in 411-Patient Myriad Soft Tissue Reconstruction Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398527","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398527?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:47","pubTimestamp":1788742049,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery reports low infection rates in 411-patient Myriad soft tissue reconstruction studyAroa Biosurgery announced peer-reviewed interim results from its ongoing MASTRR Registry evaluating My","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL45rQDX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ARX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800754","title":"Aroa Biosurgery Says Study Interim Results Show Low Infection Rates, No Adverse Events Related to Myriad Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800754","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800754?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:57","pubTimestamp":1788483446,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery  interim results from its study, which included 411 patients enrolled in the MASTRR Registry across 10 US centers and representing 474 soft tissue defects, reported low infection rates and no adverse events related to its Myriad products, according to a Friday Australian bourse filing.The ongoing prospective observational study is evaluating the real-world safety and performance of the Myriad Matrix and Myriad Morcells products across a range of complex soft tissue reconstruction procedures. The interim results were published in Advances in Therapy.Deep tissue infection occurred in only 0.7% of patients and superficial infection in 2.9%, according to the results. No infections were attributed to Myriad products, over a median follow-up period of 27 weeks. Across the 474 defects, the median number of Myriad product applications was one.Over 550 patients have been enrolled, and the registry is approved to enrol up to 800 patients across 15 sites in the US.Its shares rose ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820966","title":"ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820966","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820966?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:04","pubTimestamp":1787598287,"startTime":"0","endTime":"0","summary":"As the Australian market looks to start the week on a positive note, buoyed by encouraging movements on Wall Street and a resilient commodities sector, investors are keenly observing opportunities for growth amidst fluctuating economic indicators like unemployment rates. In this environment, identifying stocks trading below their intrinsic value can offer potential advantages, as these investments may provide room for appreciation when market confidence is bolstered by favorable global and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/telecom/asx-slc/superloop-shares/news/asx-august-2026-stocks-estimated-to-be-trading-below-intrins","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","BK7505","BK7094","BK7141","RDY.AU","SLC.AU","BK7126","BGL.AU","TLX","BK7067","BK4585","BK7084","BK7508","BK4588","ELS.AU","BK4139","PNV.AU","BK7501","MSB.AU","TEA.AU","ARX.AU","TLX.AU","ING.AU","BK7016","BK7015","BK7055","CGS.AU","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661468342","title":"ASX Value Picks ALS And Two More Stocks Estimated Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2661468342","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661468342?lang=en_us&edition=fundamental","pubTime":"2026-08-24 03:04","pubTimestamp":1787511862,"startTime":"0","endTime":"0","summary":"As the Australian market braces for a soft opening amid global tensions and fluctuating oil prices, investors are keenly observing the impact of these developments on local indices. In such a climate, identifying stocks that are trading below their intrinsic value can present opportunities for those looking to capitalize on potential market inefficiencies.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9612012-choice1-main-header/1585186781062","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612012-choice1-main-header/1585186781062"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/commercial-services/asx-alq/als-shares/news/asx-value-picks-als-and-two-more-stocks-estimated-below-intr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/commercial-services/asx-alq/als-shares/news/asx-value-picks-als-and-two-more-stocks-estimated-below-intr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7055","NXL.AU","SLC.AU","BK7501","SYL.AU","RDY.AU","ARX.AU","BK7084","BK7050","ING.AU","BK7067","BGL.AU","TPW.AU","MSB.AU","BK7016","BK7015","BK7505","BK7049","BK7508","ALQ.AU","TLX.AU","ELS.AU","BK7104","BK7126","BK7107","BK7141","PNV.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ARX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}